PCOS Fertility Treatment in India: Letrozole, IUI, IVF and Success Rates

• Around 7 in 10 women with PCOS need some help to conceive, but most do go on to have children — PCOS is treatable, not permanent infertility.
• The problem is almost always anovulation (no egg released). Treatment works by restoring or inducing ovulation, in a clear step-by-step ladder.
• For women who are overweight, a 5–10% weight loss can restore ovulation on its own — it is the genuine first-line treatment.
• Letrozole has overtaken clomiphene as the first-choice ovulation drug for PCOS because it leads to more live births with milder side effects.
• Most women conceive on simple, low-cost treatment long before IVF is needed. IVF is reserved for when earlier steps fail or other factors are present.
• Seek help earlier than usual: after 6–12 months of trying rather than waiting a full year, especially if your cycles are irregular.

PCOS is the leading cause of anovulatory infertility worldwide, and in Indian fertility clinics roughly one in three women coming in for help to conceive has PCOS as the primary diagnosis. The mechanism is simple to picture. The hormonal imbalance of PCOS — excess luteinising hormone (LH), raised androgens, and insulin resistance — interferes with the normal monthly maturation and release of an egg. So cycles either stretch out to 35–60 days or skip for months at a time. Without ovulation there is no egg for sperm to meet, so pregnancy cannot happen however long a couple tries. If you are unsure whether you are ovulating at all, our explainer on what ovulation actually means and the signs of irregular periods are a good starting point.

Around 70% of women with PCOS report some difficulty conceiving, but that number deserves nuance. Many conceive in their first or second year of trying with no treatment at all, especially when cycles are only mildly irregular. Others need a few cycles of letrozole or clomiphene and conceive within six months. A smaller group needs IUI or IVF. The honest framing for a newly diagnosed woman is this: PCOS is not a sentence of infertility — it is a strong prompt to plan pregnancy with awareness, to seek help earlier rather than later, and to expect treatment to work, because for the great majority of Indian women with PCOS, it does. It helps to know that PCOS isn't your fault; it is a common, manageable hormonal condition.

For women with PCOS who are overweight or obese, lifestyle change is the genuine first-line of fertility treatment, and the evidence is striking: a 5–10% reduction in body weight restores ovulation in roughly half of women, often with no medication at all. Fat tissue produces extra estrogen and worsens insulin resistance, both of which suppress ovulation — so even modest weight loss can reset the hormonal balance and bring back regular cycles. For a woman weighing 70 kg, losing 4–7 kg is enough to make a meaningful difference, and the same proportional principle applies at every weight band. (Weight is one factor among many — lean women get PCOS too, and the goal is metabolic health, not a number on the scale.)

The India-friendly approach centres on a lower-glycaemic-index diet: millets like ragi, jowar and bajra in place of white rice and refined wheat; generous vegetables; dal, paneer and eggs for protein; and moderation of sweets, fried snacks and sugary chai. Add 150 minutes a week of moderate activity (brisk walking, cycling, swimming, or yoga), aim for 7–8 hours of sleep, and treat stress as a hormonal issue rather than a personality flaw. Results take 3–6 months to show up in cycle regularity, so patience matters. For a deeper dive into eating well with PCOS, see our guides to the anti-PCOS diet that actually works and broader PCOS treatment options.

Metformin (sold in India as Glycomet, Glyciphage, Obimet and other brands, roughly ₹50–150 for a month's supply) is widely prescribed by Indian fertility specialists as part of PCOS care, particularly when insulin resistance is documented or strongly suspected. By improving the body's response to insulin and lowering circulating insulin, metformin indirectly reduces ovarian androgen production and can restore spontaneous ovulation in around a quarter of women without any other fertility medication. A typical regimen starts at 500 mg once daily with the largest meal, increased gradually over 2–4 weeks to 1500–2000 mg per day in divided doses to limit the common side effects of nausea, bloating and loose stools.

Metformin works best alongside lifestyle measures and is often continued with letrozole or clomiphene to improve overall response to ovulation induction. It is not a fertility drug in the strict sense — it does not trigger ovulation the way letrozole does — but it improves the hormonal environment in which ovulation and pregnancy can happen. Many Indian obstetricians and fertility specialists are comfortable continuing metformin into the first trimester when pregnancy is achieved, supported by a reassuring body of safety evidence, though this is always an individual decision with your treating doctor. If your periods are irregular, it is also worth checking related causes such as thyroid problems and high prolactin, which can coexist with PCOS.

Letrozole (sold in India as Letoval, Fertyl-L, Letovar and Femara, roughly ₹50–200 for a strip of five 2.5 mg tablets) has become the first-line ovulation-induction drug for PCOS over the last decade, displacing clomiphene from that role. Large trials — including the US NIH Reproductive Medicine Network study — showed that letrozole produces more live births in women with PCOS than clomiphene, with comparable safety. The usual regimen is 2.5 mg once daily on days 2 to 6 of the cycle, increased to 5 mg in the next cycle if ovulation does not occur, and occasionally to 7.5 mg.

Ovulation rates with letrozole in PCOS are around 75–85% per treated cycle, and pregnancy rates are about 25–30% per cycle in women who ovulate, with cumulative pregnancy over six cycles approaching 60–70%. Side effects are usually mild — hot flushes, headaches, occasional fatigue — and far better tolerated than clomiphene's mood and visual effects. Monitoring is typically a mid-cycle transvaginal ultrasound to confirm a follicle is growing, with timed intercourse or IUI planned around the predicted ovulation day. Tracking your fertile window helps: see our guides to ovulation test kits in India and understanding cervical mucus. Most Indian specialists run 3–6 letrozole cycles before stepping up.

Clomiphene citrate (sold in India as Fertyl, Clofert, Ovofar and Siphene, roughly ₹50–200 per strip) was the standard first-line ovulation drug for decades and is still widely used in Indian practice, particularly in smaller centres or where letrozole is not stocked. The usual dose is 50 mg once daily on days 2 to 6 of the cycle, stepped up to 100 mg and occasionally 150 mg if ovulation does not occur. Ovulation rates in PCOS are around 70–75%, but pregnancy rates run lower than with letrozole because clomiphene can thin the endometrial lining and dry cervical mucus — both of which work against implantation.

Side effects include mood swings, hot flushes, breast tenderness, occasional visual disturbances (which mean stopping the drug), and a small but real rise in the chance of twins (around 5–10% versus 1–2% with natural conception). International consensus limits clomiphene to a maximum of about six cycles in any one woman, because use beyond that does not improve pregnancy rates and may carry a small theoretical increase in ovarian cancer risk. If clomiphene fails after six cycles, the standard next steps are to switch to letrozole or move up to gonadotropins or IUI.

When letrozole and clomiphene fail to produce ovulation or pregnancy after several cycles, the next step is injectable gonadotropins — recombinant FSH (Gonal-F, Recagon, Folisurge) or urinary FSH and HMG preparations (Menopur, IVF-M), costing roughly ₹500–1500 per dose in India. These directly stimulate the ovaries to recruit and grow follicles, and require close monitoring with frequent transvaginal ultrasound scans (usually every 2–3 days) and serum estradiol measurements to track follicle development and guard against overstimulation.

The risk of ovarian hyperstimulation syndrome (OHSS) is meaningfully higher in PCOS because of the large pool of small follicles, so protocols are deliberately conservative — low starting doses, slow increases, and a readiness to cancel the cycle if too many follicles develop. Multiple-pregnancy risk is also higher (10–30% twins or triplets depending on protocol), which is why gonadotropin cycles in PCOS are usually paired with IUI rather than timed intercourse, for better control. A single gonadotropin-stimulated cycle in India typically runs ₹15,000 to ₹40,000 depending on dose and duration, and most specialists try 3–4 cycles before recommending IVF if pregnancy has not occurred.

Intrauterine insemination (IUI) is the usual next step when oral ovulation induction with timed intercourse has not worked after several cycles, and it is almost always combined with letrozole or low-dose gonadotropin stimulation rather than done in a natural cycle. The procedure itself is quick: on the predicted day of ovulation, a sample of the partner's washed and concentrated sperm is placed directly into the uterine cavity through a thin catheter, bypassing the cervix and shortening the distance sperm must travel to reach the egg. Where male factor is suspected, a semen analysis comes first — our guide to male fertility myths versus reality is worth a read, since male factor contributes to a large share of couples' difficulty.

Success rates per IUI cycle in PCOS with ovulation induction are around 10–20%, depending on age, sperm quality and number of attempts, with cumulative success over 3–6 cycles reaching 40–50%. Cost in private Indian clinics is roughly ₹15,000–30,000 per cycle including medication, monitoring scans and the procedure; in big metros like Mumbai, Delhi and Bengaluru, costs trend higher. Most specialists run 3–6 IUI cycles before recommending IVF, beyond which cumulative success drops sharply. For a cycle-by-cycle breakdown see our dedicated guide to IUI in India: cost and process. A blocked fallopian tube changes the plan — tubal patency is usually checked first with an HSG test.

IVF (in-vitro fertilisation) is the definitive step when earlier treatments have not worked, and women with PCOS generally do very well in IVF because of their large pool of available follicles. Major Indian chains — Apollo Fertility, Nova IVF, Indira IVF, Bloom IVF and Cloudnine — charge roughly ₹1.5–3.5 lakh per IVF cycle including medications, with ICSI (intracytoplasmic sperm injection) adding ₹30,000–50,000 if male-factor issues are also present. A frozen embryo transfer cycle costs an additional ₹50,000–1,00,000.

PCOS-specific IVF protocols favour the antagonist protocol over long agonist protocols because it carries a lower risk of OHSS, the main complication concern in PCOS-IVF. "Freeze-all" strategies — freezing all good embryos and transferring them in a later cycle rather than fresh — reduce OHSS risk further and give similar or better pregnancy rates. Per-cycle live birth rates in good Indian centres are around 40–50% for women under 35 with PCOS, dropping to 25–35% in the late 30s and 10–20% over 40. Cumulative success over 2–3 cycles often reaches 60–70% in younger women, making IVF a genuinely high-probability option when other paths have not worked. For the full picture see our guide to IVF in India: cost, process and success rates. Because success falls with age, women planning to delay may also consider egg freezing.

For PCOS fertility care, the right specialist is a fertility specialist (reproductive endocrinologist), ideally a member of the Indian Society for Assisted Reproduction (ISAR) with fellowship training in reproductive medicine. General gynaecologists can manage simple letrozole cycles for mild PCOS, but anything requiring gonadotropin stimulation, IUI or IVF needs a specialist centre. Major chains with strong PCOS fertility programmes include Apollo Fertility (most metros), Nova IVF Fertility (Mumbai, Delhi, Bengaluru, Hyderabad, Chennai, Pune), Indira IVF (the largest national network), Bloom IVF (Mumbai) and Cloudnine Fertility (Bengaluru and other metros), with consultation fees typically ₹800–2500.

What to look for: ISAR membership, transparent reporting of cycle success (live birth rates broken down by age, not just pregnancy rates), a clear written cost breakdown before starting, proven ability with PCOS-specific protocols, and genuine counselling and emotional support — fertility treatment is hard emotionally as well as financially, and the human side of a clinic matters. Avoid centres that pressure quick decisions, refuse to share their actual age-banded success rates, or quote a flat package without an itemised breakdown. If you have conceived before but are now struggling, our guide to secondary infertility explains how the workup differs.

You do not have to wait a full year to ask for help when you have PCOS. The standard advice to try for 12 months before seeking a workup is meant for couples with regular cycles — with PCOS and irregular ovulation, earlier review is sensible.

See a doctor or fertility specialist if any of the following apply.

Here is roughly what the complete PCOS fertility pathway costs in 2026 rupees. Lifestyle and metformin: ₹500–2000 per month for clinic visits and medication. Letrozole or clomiphene with monitoring scans: ₹3000–8000 per cycle (medication ₹100–300, two monitoring ultrasounds ₹1500–3000 each, follow-up ₹500–1500). IUI with ovulation induction: ₹15,000–30,000 per cycle. Gonadotropin-stimulated IUI: ₹30,000–50,000 per cycle. IVF without ICSI: ₹1.5–2.5 lakh per cycle. IVF with ICSI: ₹2–3.5 lakh per cycle. Frozen embryo transfer: an additional ₹50,000–1,00,000.

Insurance coverage for fertility treatment in India is improving but remains limited and inconsistent. Some private insurers (Star, HDFC ERGO, Bajaj Allianz, Niva Bupa) now cover fertility treatment under maternity riders or premium plans, typically with lifetime limits of ₹1–3 lakh and waiting periods of 2–4 years. A few states (including Tamil Nadu, Andhra Pradesh, Telangana and Maharashtra) have started limited public IVF schemes, but eligibility is restricted by income and condition. Most Indian couples still pay out of pocket, so budgeting for the full pathway up to and including 1–2 IVF cycles is sensible. Optimising health before you start — weight, vitamin D, thyroid and metabolic health — protects both fertility and the pregnancy that follows; once pregnant, women with PCOS need early gestational diabetes screening and the extra care covered in PCOS and pregnancy.

• WHO — Polycystic ovary syndrome (fact sheet)
• International evidence-based guideline for the assessment and management of PCOS (2023, ESHRE/ASRM/Monash)
• Legro RS et al. Letrozole versus Clomiphene for Infertility in PCOS — NEJM (NIH Reproductive Medicine Network)
• NICE — Fertility problems: assessment and treatment (CG156)
• ACOG — Polycystic Ovary Syndrome (PCOS) FAQ